The Columbia River Oncology Program

Thursday, July 02, 2009

CROP Home

Research Studies

Cancer Control Studies

Members

		New Open Studies

CALGB 070604: A Randomized, Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer

SWOG S0703: A Phase II Trial of Azacitidine plus Gemtuzumab Ozogamicin as Induction and Post-Remission Therapy in Older Patients With Previously Untreated Non-M3 Acute Myeloid Leukemia

NSABP B43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

		CROP Members

Adventist Medical Center

Legacy Health System

Northwest Cancer Specialists

Providence Health System

Southwest Washington Medical Center

		Welcome to the Columbia River Oncology Program!

The Columbia River Oncology Program (CROP) is a Community Clinical Oncology Program (CCOP) currently in its 23rd year. The National Cancer Institute (NCI) oversees this program. Consortium affiliates include health care systems and providers in the metropolitan Portland, Oregon and Vancouver, Washington area.

Adventist Medical Center, Legacy Health System, Northwest Cancer Specialists, Providence Health System, and Southwest Washington Medical Center take part in CROP. CROP provides state of the art clinical trials in cancer prevention, symptom control and treatments, advancing the knowledge of cancer and improving the health of our community.

CROP's Research Bases

CROP's Goals

		CROP Open Studies

Title	Owner	Category	Last Updated	Size (KB)
CROP Open List	Administrator Account		6/30/2009	168.68	Download
CROP Open Poster	Administrator Account		6/30/2009	91.62	Download
Open & Closure Log	Administrator Account		6/2/2009	50.18	Download

		Disease Site Search

Disease Site: